Category: Editors’ Pick

Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations

The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.

The Billionaire Chairman Of Vaccine Maker Moderna Wants To Reinvent Scientific Entrepreneurship

Noubar Afeyan launched 70 companies by pushing researchers to ask what if their craziest ideas were true. With $17 billion and a model of “parallel entrepreneurship,” he can fund a lot of wild notions.

Medicare Part B Premiums To Rise 14.5% In 2022, With Premiums For Highest-Income Couples Nearly $14,000 A Year

Some 7% of Medicare recipients pay income-related surcharges on their Part B premiums, and they’re up 14.5% for 2022.

InnovationRx: Healthcare Price Deflation?; Plus, Germany, France Restrict Moderna Shots Under 30

InnovationRx is your weekly digest of healthcare news. Sign up!

These Former Googlers Raised $30 Million To Automate Phone Calls With Health Insurers

Infinitus Systems cofounders Ankit Jain and Shyam Rajagopalan have developed a robot to automate one of the most tedious and time consuming administrative processes in healthcare: verifying insurance benefits.

These Former Googlers Raised $30 Million To Automate Phone Calls With Health Insurers

Infinitus Systems cofounders Ankit Jain and Shyam Rajagopalan have developed a robot to automate one of the most tedious and time consuming administrative processes in healthcare: verifying insurance benefits.

This Company Has Applied For Authorization In India For Its Nasal Spray That Prevents Covid

Ireland-based pHOXBIO’s medicine was shown to provide protection against Covid in clinical trials.

Politics Aside, The Biden Administration’s Vaccine Mandates Are Lawful

Public health law experts Lawrence Gostin, Alexandra Finch and James Hodge explain why the Biden Administration’s vaccine mandates will survive legal scrutiny – and why their politicization makes for a rocky road ahead.

Impact Of Covid-19 Pandemic Extends To Tuberculosis And Neglected Tropical Diseases

Tuberculosis and neglected tropical diseases have been negatively impacted by the Covid-19 pandemic, as resources have been diverted to the Covid-19 response. This has caused an acute disruption of activities aimed at disease diagnosis, control, and el…

Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical Study

The pharmaceutical giant will submit the data to the FDA to continue its application for emergency use authorization.